Dudediligence.

AbbVie Inc

ABBVNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$14.46BSep ’24$15.10BDec ’24$13.34BMar ’25$15.42BJun ’25$15.78BSep ’25$16.62BDec ’25$15.00BMar ’26$16.99BJun ’26
Net income, by quarter
$1.56BSep ’24−$22.0MDec ’24$1.29BMar ’25$938.0MJun ’25$186.0MSep ’25$1.82BDec ’25$695.0MMar ’26$3.61BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$56.20B$58.05B$54.32B$56.33B$61.16B
Gross profit$38.75B$40.64B$33.90B$39.43B$42.96B
Operating income$17.92B$18.12B$12.76B$9.14B$15.07B
Net income$11.54B$11.84B$4.86B$4.28B$4.23B
Operating cash flow$22.78B$24.94B$22.84B$18.81B$19.03B
Free cash flow$21.99B$24.25B$22.06B$17.83B$17.82B
Cash$9.75B$9.20B$12.81B$5.52B$5.23B
Debt$76.67B$63.27B$59.38B$67.14B$70.56B
Shares outstanding1.80B1.81B1.82B1.83B1.84B